San Diego, CA, United States of America

Sarah Sanders

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Reprohealth Technologies, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sarah Sanders: Innovator in RNA Polymerase Research

Introduction

Sarah Sanders is a notable inventor based in the United States, recognized for her contributions to the field of RNA polymerase research. Although she currently holds no patents, her work has significant implications for cancer treatment and understanding ribosomal RNA transcription.

Latest Patents

One of her key inventions is related to Benzo[g]pyrido[2,1-B] Quinazoline Carboxamide Compounds, which inhibit RNA polymerase. This invention focuses on RNA polymerase I (Pol I), a crucial enzyme responsible for transcribing the 47S ribosomal RNA precursor. This precursor is subsequently processed into mature ribosomal RNAs, which are essential for ribosome assembly in the nucleolus. The invention identifies a set of bioactive compounds that can cause RPA194 degradation, functioning within a tightly constrained chemical space. The compounds provided in this invention include pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs. Additionally, pharmaceutical compositions comprising these compounds are proposed for use in cancer and other Pol I-related diseases.

Career Highlights

Throughout her career, Sarah has worked with prestigious institutions, including The Johns Hopkins University and the Lieber Institute for Brain Development. Her research has contributed to a deeper understanding of the mechanisms underlying RNA polymerase activity and its deregulation in human cancers.

Collaborations

Sarah has collaborated with esteemed colleagues, including Marikki Laiho and Laureen Colis, to advance her research and explore innovative solutions in the field of molecular biology.

Conclusion

In summary, Sarah Sanders is an innovative researcher whose work on RNA polymerase has the potential to impact cancer treatment significantly. Her contributions to the scientific community continue to pave the way for future advancements in this critical area of study.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…